{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T02:23:29Z","timestamp":1787624609529,"version":"build-2736575974"},"reference-count":75,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Biliary tract cancers (BTCs), a group of rare aggressive malignancies, posed significant clinical challenges due to late diagnosis and limited therapies. While gut microbiota had been extensively studied in gastrointestinal cancers, the role of oral microbiota\u2014a primary microbial reservoir entering the digestive system\u2014remained poorly understood. Emerging evidence indicated that oral bacteria might affect biliary carcinogenesis through direct colonization, immune modulation, and metabolic interactions via the oral-gut-liver axis. This narrative review analyzed current research connecting oral microbial imbalance with BTCs. It explored how bacterial translocation, inflammatory metabolites, and immune alterations could promote cancer development. Established BTC risk factors\u2014including gallstones, primary sclerosing cholangitis, cirrhosis, and <jats:italic>H. pylori<\/jats:italic> infection\u2014were evaluated for their associations with oral microbiota changes. Epidemiological studies revealed that periodontal disease and poor oral hygiene elevated BTC risk. Sequencing analyses identified oral-origin bacteria (<jats:italic>Prevotella<\/jats:italic>, <jats:italic>Fusobacterium<\/jats:italic>, <jats:italic>Streptococcus<\/jats:italic>) in bile and tumor tissues, suggesting microbial migration through swallowing or bloodstream. Mechanistic investigations showed microbial components (e.g., lipopolysaccharides, membrane vesicles) activated inflammatory pathways (TLR4\/NF-\u03baB, STAT3) and modified immune checkpoints, while metabolites potentially altered biliary cell metabolism. Different studies have found variable changes in oral microbiota in the presence of BTCs, thus a novel \u201cbiphasic dysbiosis\u201d hypothesis was proposed to explain differing oral microbial diversity patterns across BTC subtypes. Despite progress, critical knowledge gaps persisted regarding causality, spatial microbial variations, and functional impacts of metabolites in BTCs. Future research was recommended to employ multi-omics approaches, single-cell analysis, and AI tools to enhance early detection and prevention strategies.<\/jats:p>","DOI":"10.3389\/fonc.2025.1585923","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T05:15:13Z","timestamp":1749618913000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Oral microbiota and biliary tract cancers: unveiling hidden mechanistic links"],"prefix":"10.3389","volume":"15","author":[{"given":"Yuhan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s40168-020-00875-0","article-title":"Microbiome definition re-visited: old concepts and new challenges","volume":"8","author":"Berg","year":"2020","journal-title":"Microbiome"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-16-0249","article-title":"The Human Microbiome and Cancer","volume":"10","author":"Rajagopala","year":"2017","journal-title":"Cancer Prev Res"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/nrg3182","article-title":"The Human Microbiome: at the interface of health and disease","volume":"13","author":"Cho","year":"2012","journal-title":"Nat Rev Genet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12866-020-01801-y","article-title":"Defining the oral microbiome by whole-genome sequencing and resistome analysis: the complexity of the healthy picture","volume":"20","author":"Caselli","year":"2020","journal-title":"BMC Microbiol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00153-7","article-title":"Biliary tract cancer","volume":"397","author":"Valle","year":"2021","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.02178","article-title":"Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline","volume":"37","author":"Shroff","year":"2019","journal-title":"JCO"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2011.131","article-title":"Clinical diagnosis and staging of cholangiocarcinoma","volume":"8","author":"Blechacz","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-0122","article-title":"Tumor microenvironment complexity: emerging roles in cancer therapy","volume":"72","author":"Swartz","year":"2012","journal-title":"Cancer Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro3344","article-title":"The gut microbiota, bacterial metabolites and colorectal cancer","volume":"12","author":"Louis","year":"2014","journal-title":"Nat Rev Microbiol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25136971","article-title":"The Postbiotic Properties of Butyrate in the Modulation of the Gut Microbiota: The Potential of Its Combination with Polyphenols and Dietary Fibers","volume":"25","author":"Maiuolo","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.37349\/emed.2024.00241","article-title":"Comparative analysis of dysbiotic changes in the oral cavity of patients with periodontal diseases and systemic pathologies","volume":"5","author":"Denefil","year":"2024","journal-title":"Explor Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/prd.12387","article-title":"Periodontal disease\u2013related nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: An emerging concept of oral-liver axis","volume":"2000","author":"Kuraji","year":"2021","journal-title":"Periodontol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2020.11.004","article-title":"The Oral Host-Microbial Interactome: An Ecological Chronometer of Health","volume":"29","author":"Freire","year":"2021","journal-title":"Trends Microbiol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-310101","article-title":"Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis","volume":"65","author":"Mima","year":"2016","journal-title":"Gut"},{"key":"B15","doi-asserted-by":"publisher","first-page":"i136","DOI":"10.1093\/ecco-jcc\/jjae190.0065","article-title":"DOP026 Porphyromonas gingivalis secreted htpG disrupts TLR4\/PAPSS2-mediated mucin sulfation and aggravates ulcerative colitis","volume":"19","author":"Wang","year":"2025","journal-title":"J Crohn\u2019s Colitis"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2388801","article-title":"Porphyromonas gingivalis fuels colorectal cancer through CHI3L1-mediated iNKT cell-driven immune evasion","volume":"16","author":"D\u00edaz-Basabe","year":"2024","journal-title":"Gut Microbes"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2023.105250","article-title":"Porphyromonas gingivalis as a promotor in the development of the alcoholic liver disease via ferroptosis","volume":"26","author":"Yao","year":"2024","journal-title":"Microbes Infect"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1409644111","article-title":"Oligotyping analysis of the human oral microbiome","volume":"111","author":"Eren","year":"2014","journal-title":"Proc Natl Acad Sci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.43.11.5721-5732.2005","article-title":"Defining the Normal Bacterial Flora of the Oral Cavity","volume":"43","author":"Aas","year":"2005","journal-title":"J Clin Microbiol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/ismej.2010.30","article-title":"Bacterial diversity in the oral cavity of ten healthy individuals","volume":"4","author":"Bik","year":"2010","journal-title":"ISME J"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan4526","article-title":"Ectopic colonization of oral bacteria in the intestine drives TH1 cell induction and inflammation","volume":"358","author":"Atarashi","year":"2017","journal-title":"Science"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/odi.13044","article-title":"Influence of Porphyromonas gingivalis in gut microbiota of streptozotocin-induced diabetic mice","volume":"25","author":"Ohtsu","year":"2019","journal-title":"Oral Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41575-018-0011-z","article-title":"The gut-liver axis and the intersection with the microbiome","volume":"15","author":"Tripathi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"eaan5931","DOI":"10.1126\/science.aan5931","article-title":"Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells","volume":"360","author":"Ma","year":"2018","journal-title":"Science"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-14-1110","article-title":"The association between the upper digestive tract microbiota by HOMIM and oral health in a population-based study in Linxian, China","volume":"14","author":"Yu","year":"2014","journal-title":"BMC Public Health"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-17-0212","article-title":"Periodontal Disease and Incident Cancer Risk among Postmenopausal Women: Results from the Women\u2019s Health Initiative Observational Cohort","volume":"26","author":"Nwizu","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1177\/20506406198580433","article-title":"The association between self-reported poor oral health and gastrointestinal cancer risk in the UK Biobank: A large prospective cohort study","volume":"7","author":"Jord\u00e3o","year":"2019","journal-title":"U Eur Gastroenterol J"},{"key":"B28","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jhep.2021.02.011","article-title":"Bile formation and secretion: An update","volume":"75","author":"Boyer","year":"2021","journal-title":"J Hepatol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s40168-019-0712-8","article-title":"The human gallbladder microbiome is related to the physiological state and the biliary metabolic profile","volume":"7","author":"Molinero","year":"2019","journal-title":"Microbiome"},{"key":"B30","article-title":"Characteristics of bile microbiota in cholelithiasis, perihilar cholangiocarcinoma, distal cholangiocarcinoma, and pancreatic cancer","volume":"14","author":"Li","year":"2022","journal-title":"Am J Transl Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/1092563","article-title":"A Preliminary Study of Biliary Microbiota in Patients with Bile Duct Stones or Distal Cholangiocarcinoma","volume":"2019","author":"Chen","year":"2019","journal-title":"BioMed Res Int"},{"key":"B32","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ebiom.2016.04.034","article-title":"Tissue Microbiome Profiling Identifies an Enrichment of Specific Enteric Bacteria in Opisthorchis viverrini Associated Cholangiocarcinoma","volume":"8","author":"Chng","year":"2016","journal-title":"EBioMedicine"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s00253-022-12333-y","article-title":"Pseudomonadota in the oral cavity: a glimpse into the environment-human nexus","volume":"107","author":"Le\u00e3o","year":"2023","journal-title":"Appl Microbiol Biotechnol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1128\/JB.00542-10","article-title":"The human oral microbiome","volume":"192","author":"Dewhirst","year":"2010","journal-title":"J Bacteriol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"178.e11","DOI":"10.1016\/j.cmi.2015.10.008","article-title":"Microbiota studies in the bile duct strongly suggest a role for Helicobacter pylori in extrahepatic cholangiocarcinoma","volume":"22","author":"Avil\u00e9s-Jim\u00e9nez","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms13010119","article-title":"Unveiling Microbiota Profiles in Saliva and Pancreatic Tissues of Patients with Pancreatic Cancer","volume":"13","author":"Uguz","year":"2025","journal-title":"Microorganisms"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1002\/hep.25704","article-title":"The gut-liver axis: A busy two-way street","volume":"55","author":"Mehal","year":"2012","journal-title":"Hepatology"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1288525","article-title":"Elucidating the causal association between gut microbiota and intrahepatic cholangiocarcinoma through Mendelian randomization analysis","volume":"14","author":"Chen","year":"2023","journal-title":"Front Microbiol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.606986","article-title":"Lipopolysaccharide Preparation Derived From Porphyromonas gingivalis Induces a Weaker Immuno-Inflammatory Response in BV-2 Microglial Cells Than Escherichia coli by Differentially Activating TLR2\/4-Mediated NF-\u03baB\/STAT3 Signaling Pathways","volume":"11","author":"Qiu","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1159\/000490829","article-title":"Induction of Pro-Inflammatory Response via Activated Macrophage-Mediated NF-\u03baB and STAT3 Pathways in Gastric Cancer Cells","volume":"47","author":"Zhou","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"B41","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s40364-024-00607-8","article-title":"Gut microbiota and metabolites signatures of clinical response in anti-PD-1\/PD-L1 based immunotherapy of biliary tract cancer","volume":"12","author":"Zhu","year":"2024","journal-title":"Biomark Res"},{"key":"B42","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s40779-022-00423-x","article-title":"Alterations in the human oral microbiome in cholangiocarcinoma","volume":"9","author":"Rao","year":"2022","journal-title":"Military Med Res"},{"key":"B43","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12967-024-05989-9","article-title":"Metagenomic characterization of oral microbiome signatures to predict upper gastrointestinal and pancreaticobiliary cancers: a case-control study","volume":"23","author":"Oh","year":"2025","journal-title":"J Transl Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1023\/A:1013747228572","article-title":"Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case\u2013control study in Italy","volume":"12","author":"Donato","year":"2001","journal-title":"Cancer Causes Control"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2018.09.004","article-title":"Dilemma of elevated CA 19\u20139 in biliary pathology","volume":"18","author":"Tsen","year":"2018","journal-title":"Pancreatology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41522-024-00511-x","article-title":"Integrative analysis reveals associations between oral microbiota dysbiosis and host genetic and epigenetic aberrations in oral cavity squamous cell carcinoma","volume":"10","author":"Cai","year":"2024","journal-title":"NPJ Biofilms Microb"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-005-0051-8","article-title":"Epidemiology and risk factors for gallstone disease: Has the paradigm changed in the 21st century","volume":"7","author":"Shaffer","year":"2005","journal-title":"Curr Gastroenterol Rep"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1177\/1073274817729245","article-title":"Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma","volume":"24","author":"Massarweh","year":"2017","journal-title":"Cancer Control"},{"key":"B49","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.amjsurg.2006.08.001","article-title":"Biliary bacterial factors determine the path of gallstone formation","volume":"192","author":"Stewart","year":"2006","journal-title":"Am J Surg"},{"key":"B50","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1097\/MEG.0000000000000885","article-title":"Association between oral hygiene and ultrasound-confirmed gallstone disease in US population","volume":"29","author":"Bhandari","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/srep17450","article-title":"Metagenomic sequencing of bile from gallstone patients to identify different microbial community patterns and novel biliary bacteria","volume":"5","author":"Shen","year":"2015","journal-title":"Sci Rep"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e0150519","DOI":"10.1371\/journal.pone.0150519","article-title":"Influence of the Biliary System on Biliary Bacteria Revealed by Bacterial Communities of the Human Biliary and Upper Digestive Tracts","volume":"11","author":"Ye","year":"2016","journal-title":"PLoS One"},{"key":"B53","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s40001-023-01308-y","article-title":"Variations of bile bacterial community alongside gallstone disease progression and key taxa involved in poor outcomes after endoscopic surgery","volume":"28","author":"Cai","year":"2023","journal-title":"Eur J Med Res"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1608801","article-title":"The Microbiome in Primary Sclerosing Cholangitis: Current Evidence and Potential Concepts","volume":"37","author":"Hov","year":"2017","journal-title":"Semin Liver Dis"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15375","article-title":"Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitis","volume":"50","author":"R\u00fchlemann","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v23.i25.4548","article-title":"Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis","volume":"23","author":"Bajer","year":"2017","journal-title":"World J Gastroenterol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s12072-020-10089-z","article-title":"Alterations of the salivary and fecal microbiome in patients with primary sclerosing cholangitis","volume":"15","author":"Lapidot","year":"2021","journal-title":"Hepatol Int"},{"key":"B58","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/liv.15152","article-title":"Preneoplastic lesions in the liver: Molecular insights and relevance for clinical practice","volume":"42","author":"Desjonqueres","year":"2022","journal-title":"Liver Int"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1111\/odi.14785","article-title":"Periodontitis and NAFLD-related diseases: A bidirectional two-sample Mendelian randomization study","volume":"30","author":"Qiao","year":"2024","journal-title":"Oral Dis"},{"key":"B60","doi-asserted-by":"publisher","first-page":"13621","DOI":"10.1038\/s41598-022-17917-2","article-title":"A cross-sectional study assessing the relationship between non-alcoholic fatty liver disease and periodontal disease","volume":"12","author":"Sato","year":"2022","journal-title":"Sci Rep"},{"key":"B61","doi-asserted-by":"publisher","first-page":"10718","DOI":"10.1038\/s41598-018-28905-w","article-title":"Unique subgingival microbiota associated with periodontitis in cirrhosis patients","volume":"8","author":"Jensen","year":"2018","journal-title":"Sci Rep"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00230.2018","article-title":"Periodontal therapy favorably modulates the oral-gut-hepatic axis in cirrhosis","volume":"315","author":"Bajaj","year":"2018","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1002\/hep.27819","article-title":"Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy","volume":"62","author":"Bajaj","year":"2015","journal-title":"Hepatology"},{"key":"B64","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12879-015-0977-x","article-title":"Alterations of Bacteroides sp., Neisseria sp., Actinomyces sp., and Streptococcus sp. populations in the oropharyngeal microbiome are associated with liver cirrhosis and pneumonia","volume":"15","author":"Lu","year":"2015","journal-title":"BMC Infect Dis"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2022.02.020","article-title":"Lantibiotic-encoding Streptococcus in the human microbiome are underlying risk factors for liver diseases","volume":"84","author":"Jia","year":"2022","journal-title":"J Infect"},{"key":"B66","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nature13568","article-title":"Alterations of the human gut microbiome in liver cirrhosis","volume":"513","author":"Qin","year":"2014","journal-title":"Nature"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713470","article-title":"Effect of Liver Fibrosis on Oral and Gut Microbiota in the Japanese General Population Determined by Evaluating the FibroScan-Aspartate Aminotransferase Score","volume":"24","author":"Sato","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B68","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/MEG.0b013e32835c0362","article-title":"Infections of Helicobacter spp. in the biliary system are associated with biliary tract cancer: a meta-analysis","volume":"25","author":"Zhou","year":"2013","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"e12786","DOI":"10.1111\/hel.12786","article-title":"Helicobacter pylori infection is associated with the co-occurrence of bacteria in the oral cavity and the gastric mucosa","volume":"26","author":"Wu","year":"2021","journal-title":"Helicobacter"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-312904","article-title":"The active bacterial assemblages of the upper GI tract in individuals with and without Helicobacter infection","volume":"67","author":"Schulz","year":"2018","journal-title":"Gut"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.914418","article-title":"The interactions between oral-gut axis microbiota and Helicobacter pylori","volume":"12","author":"Chen","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2201159","article-title":"A distinct microbiota signature precedes the clinical diagnosis of hepatocellular carcinoma","volume":"15","author":"Yang","year":"2023","journal-title":"Gut Microbes"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1080\/20002297.2025.2487645","article-title":"Tongue coating microbiota-based machine learning for diagnosing digestive system tumours","volume":"17","author":"Ma","year":"2025","journal-title":"J Oral Microbiol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.109294","article-title":"Highly accurate diagnosis of pancreatic cancer by integrative modeling using gut microbiome and exposome data","volume":"27","author":"Zhang","year":"2024","journal-title":"iScience"},{"key":"B75","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.chembiol.2024.10.013","article-title":"A yeast-based oral therapeutic delivers immune checkpoint inhibitors to reduce intestinal tumor burden","volume":"32","author":"Rebeck","year":"2025","journal-title":"Cell Chem Biol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1585923\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T05:15:13Z","timestamp":1749618913000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1585923\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,11]]},"references-count":75,"alternative-id":["10.3389\/fonc.2025.1585923"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1585923","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,11]]},"article-number":"1585923"}}